>Just like those two onc. biotechs saying their drug is approved for commercial use in Switzerland when they really have something like an IND and an import/export license. Those 2 PR's were flagrant lies.<
The two cases (NWBO and Vaccinogen) were almost certainly related. Vaccinogen noticed that NWBO got away with a scam pump job that produced nary a peep from the SEC. I expect to see more of these PR’s about Swiss “approvals” if nothing is done to stop them.
>> New Advances in Chemotherapy: 'The Proof May be in the Sugar' Says Researchers [sic]
Source: Pro-Pharmaceuticals December 18, 2003
…“Once the results of the Phase l human trials are reported to the Food and Drug Administration, the FDA will decide whether DAVANAT-1 should be added to the arsenal of cancer fighting drugs.” <<
LMAO—when was the last time the FDA approved a drug based on phase-1 data?
I do have to give PRW some credit, however: it’s now five years later and they’ve advanced to phase-2. So they’re making some headway :-)
Market Data 
Markets 
AI
